Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shepherd Investments International was a prominent investment vehicle managed by Stark Investments, a global multi-strategy hedge fund based in Milwaukee, Wisconsin. During the late 1990s and 2000s, the fund was a prolific investor in the biotechnology and life sciences sectors, frequently participating in Private Investment in Public Equity (PIPE) financing for small-cap development-stage companies. The firm provided critical capital to numerous healthcare entities across therapeutic areas such as oncology, neurology, and regenerative medicine. While it held significant stakes in many biotech organizations, it functioned strictly as a financial entity rather than a drug development company. The fund's activity ceased as its parent company, Stark Investments, wound down its operations in the early 2010s.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shepherd Investments International.